SCHEMBL5784227

SCHEMBL5784227

CC(NC(=O)Cc1cccc(Oc2ccccc2)c1)C(=O)Nc1cc(C(C)(C)C)on1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 16/20 0.56
MAPK13 O15264 1/20 0.55
MAPK12 P53778 1/20 0.55
MAPK11 Q15759 1/20 0.55
MAPK14 Q16539 1/20 0.55
RET P07949 1/20 0.54
FLT3 P36888 1/20 0.53
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
PSMB1 P20618 1/20 0.45
PSMB8 P28062 1/20 0.45
PSMB9 P28065 1/20 0.45
PSMB5 P28074 1/20 0.45
PSMB10 P40306 1/20 0.45
PSMB2 P49721 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6468928 0.78 FAAH (0.48) MEN1KMT2APSMB1PSMB8PSMB9
SCHEMBL13199988 0.78 RET (0.62) RAF1MAPK13MAPK12MAPK11MAPK14
SCHEMBL5784425 0.75 EGFR (0.46) RAF1MAPK13MAPK14RETFLT3
SCHEMBL1846790 0.75 RAF1 (0.72) RAF1MAPK13MAPK12MAPK11MAPK14
SCHEMBL4063019 0.73 PSMB5 (0.49) PSMB1PSMB8PSMB9PSMB5PSMB10
SCHEMBL101749 0.73 RAF1 (0.64) RAF1MAPK13MAPK12MAPK11MAPK14
SCHEMBL13200555 0.72 FLT3 (0.73) RAF1MAPK13MAPK12MAPK11MAPK14
SCHEMBL13815845 0.72 RAF1 (0.72) RAF1MAPK13MAPK12MAPK11MAPK14
SCHEMBL13200476 0.72 FLT3 (0.65) RAF1MAPK13MAPK12MAPK11MAPK14
SCHEMBL5573447 0.71 RAF1 (1.00) RAF1MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636220-A1 ISOXAZOLE AND ISOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Pfizer Products Inc. (US) 2006-03-22 EP claimed
WO-2004099200-A1 ISOXAZOLE AND ISOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER PRODUCTS INC. (US) 2004-11-18 WO claimed
EP-1636220-A1 ISOXAZOLE AND ISOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Pfizer Products Inc. (US) 2006-03-22 EP disclosed
WO-2004099200-A1 ISOXAZOLE AND ISOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER PRODUCTS INC. (US) 2004-11-18 WO disclosed